About the Institute:
The origins of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) are rooted in the Indian Cancer Research Centre (ICRC), which was established in 1952 in Parel, Mumbai, under the purview of the Ministry of Health, Government of India. In 1966, ICRC was renamed the Cancer Research Institute (CRI) and amalgamated with the Tata Memorial Hospital (TMH), creating the first comprehensive cancer centre in India - the Tata Memorial Centre (TMC), an autonomous grant-in-aid institution of the Department of Atomic Energy (DAE), Government of India.
The foundation stone for this campus - the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), located near the foothills of the Sahyadri mountain ranges in Kharghar, Navi Mumbai, was formally laid in May 1997 by Dr. R. Chidambaram, Chairman, AEC and Secretary, DAE.
Today, ACTREC serves as a new state-of-the-art R&D satellite of TMC and has the specific mandate to function as a national centre for treatment, research and education in cancer. ACTREC, which at present comprises of the basic and clinical research wings and a 50-bed hospital, will carry out mission-oriented research and development on cancers prevalent in the Indian sub-continent, and where there are internationally competitive opportunities, will use state-of-the-art technology in partnership with TMH.
Mission:
The research programs at the Cancer Research Institute integrate both basic and clinical approaches to address questions related to cancer biology, cancer prevention and development of newer therapeutic modalities. The studies encompass basic tumor biology and delineation of various pathways involved in cell proliferation, differentiation, apoptosis and metastatis. Advanced optical imaging and spectroscopy are enabling the study of cancer related changes at submicroscopic levels, and the structural changes and crystal structures of key proteins in oncogenic pathways are being unraveled
